Lessons from ALLHAT: Are low budget diuretics first line therapy in hypertension?

Zeitschrift fur Kardiologie

Volumn 93, Issue 5, 2004, Pages 349-356

  Unger, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ALLHAT trial; Diabetes mellitus; Diuretics; Hypertension treatment guidelines; Review

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; CLONIDINE; DIHYDRALAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; LISINOPRIL; RESERPINE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ANKLE EDEMA; BLOOD PRESSURE; CLINICAL TRIAL; DIABETOGENECITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; GLUCOSE INTOLERANCE; HEART FAILURE; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; INCIDENCE; REVIEW; SIDE EFFECT; STROKE;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; DIABETES MELLITUS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; HYPOKALEMIA; MYOCARDIAL INFARCTION; PATIENT CARE MANAGEMENT; PRACTICE GUIDELINES; UNITED STATES;

EID: 2942543078     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-004-0096-y     Document Type: Review

References (22)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC et al (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 289:2560-2571
2. Guidelines Committee (2003) 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 21:1011-1053
3. Cohen HW, Madhavan S, Alderman MH (2001) High and low serum potassium associated with cardiovascular events in diuretic-treated patients. J Hypertension 19:1315-1323
4. Suter PM, Vetter W (1995) Metabolic effects of antihypertensive drugs. J Hypertension (Suppl) 13(4):S11-17
5. Unger T, Fleck T, Ganten D, Lang R (1984) Antihypertensive action of chronic treatment with piretanide in spontaneously hypertensive rats. In: Puschett JB, Greenberg A (eds) Diuretics: Chemistry, Pharmacology and Clinical Applications. Elsevier, New York Amsterdam Oxford, pp 94-102
6. Hansson L, Zanchetti A, Carruthers SC et al (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 351:1755-1762
7. Prospective Studies Collaboration (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913
8. ALLHAT Officers and Coordinators for ALLHAT (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997
9. Weber MA (2003) The ALLHAT Report: A Case of Information and Missinformation. J Clin Hypertension V(1):9-13
10. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S et al (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:995-1003
11. Furberg CD, Psaty BM, Pahor M et al (2001) Clinical implications of recent findings from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) and other studies of hypertension. Ann Intern Med 135:1074-1078
12. Neal B, MacMahon S, Chapman N for the Blood Pressure Lowering Treatment Trialist's Collaboration (2000) Effects of ACE inhibitors, calcium antagonists, and other blood pressure-Lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356:1955-1964
13. Dunder K, Lind L, Zethelius B, Berglund L, Lithell H (2003) Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. Brit Med J 326:681-685
14. Düsing R, Lehnert H (2004) Diabetogenic effect of antihypertensive treatment: primum nil nocere. Nephrol Dial Transplan 19(3):531-534
15. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB (2000) Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 35(5):1025-1030
16. Grobbee DE, Hoes AW (1995) Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertension 13:1539-1545
17. Der Spiegel (2003) Milliarden-Verschwendung mit Hochdruck-Medikamenten. der spiegel 14 www.spiegel. de/spiegel/vorab/
18. Wing LMH, Reid MC, Ryan P, Beilin LJ et al (2003) for the Second Australian National Blood Pressure Study Group. A Comparison of Outcomes with Angiotensin-Converting Enzyme Inhibitors and Diuretics for Hypertension in the Elderly. NEJM 348:583-592
19. Lauterbach KW, Plamper E (2003) Effizienz in Zeiten knapper Arzneimittelbudgets. Dtsch Ärzteblatt 100(30):C1558-C1559
20. Anlauf M, Hense HW (2003) Echte und vermeintliche Sparpotenziale in der Hochdrucktherapie: Neues aus dem Zauberhut. Dtsch Med Wochenschr 128:1557-1559
21. Weck M (2003) Studien zur Therapie der Hypertonie: Was sollen wir glauben? Dtsch. Ärzteblatt 100(30):C1559-C1560
22. Bloom BS (2001) Daily regimen and compliance with treatment. Brit Med J 323:647